Objective: To establish maternal complication rates for fetoscopic or open fetal surgery.
remainder of the index pregnancy, potentially during any future pregnancies and throughout the woman's entire life. Fetal surgery offers no direct medical benefit to the mother, and from an ethical perspective, maternal risks should be minor and acceptable to the mother and family. 2 | METHODS
| Protocol and registration
This systematic review was conducted in accordance with preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidance. 8 The protocol was registered with the international prospective register of systematic reviews (PROSPERO-CRD42017082411).
| Eligibility criteria
All randomised, cohort, and case-controlled studies and case series reporting the results of open fetal or fetoscopic fetal surgery in humans from January 1990 to October 2018 were considered eligible.
No language restrictions were applied. Systematic reviews, narrative review articles, and case reports were excluded. There is no accepted numerical definition of a case series. 9 We used an empirical cut-off of at least three cases because of the rarity of some procedures and conditions searched for.
| Search strategy
A systematic review was conducted in MEDLINE, EMBASE, and
Cochrane databases using free text and Medical Subject Headings (MESH). The electronic search strategy is described in the Supporting
Information. Subsequently, a grey literature (first 100 hits in PubMed and Google Scholar) search was performed, and reference lists of relevant review articles were manually checked. Covidence software (Veritas Health Innovation Ltd, Melbourne, Australia) was used to eliminate duplicate articles and manage study screening.
| Study selection
Two authors (A.S. and L.VdV.) screened all titles and abstracts independently, excluded irrelevant studies and then independently assessed the remaining full-text articles for eligibility; disagreements were resolved by consensus. Studies were excluded if the full text was unavailable online and the abstract contained insufficient information. Studies with interventions which were not fully described or were performed on the neonate instead of the fetus were excluded.
Interventions involving access to the uterus using a device with a total outer diameter of less than 1.5 mm were excluded; this cut-off was chosen to avoid procedures performed with needles only (eg, amniocentesis, fetal blood transfusion, thoracocentesis or vesicocentesis).
Studies of shunting were only included if the outer shunt diameter was greater than or equal to 1.5 mm or the shunt was inserted fetoscopically. Studies which did not report maternal outcomes were excluded. For the purpose of this study, preterm rupture of membranes (PROM), chorionic membrane separation (CMS), preterm labour, preterm delivery, and gestational age at delivery, although relevant, were not considered to be maternal complications. Studies from which data could not be extracted (eg, composite or combined outcomes given) and studies containing patient cohorts which appeared to have been published previously by the same authors were excluded.
What's already known about this topic?
• Fetal surgery, both open and fetoscopic, is now widely performed.
• Fetoscopy is perceived as safe for the mother, although specific data on maternal complications is lacking.
• Open fetal surgery is known to cause maternal morbidity, but the exact nature and frequency of complications is not well established across different centres and types of surgery.
What does this study add?
• This study estimates the nature and frequency of maternal complications following fetoscopic and open fetal surgery.
• For open fetal surgery, the severe complication rate (grades III to V according to the Clavien-Dindo classification of surgical complications) is approximately 4% and minor complication rate is 16%.
• For fetoscopic fetal surgery, the severe complication rate is approximately 2% and minor complication rate is 4%. were analysed using the Cochrane Collaboration's tool for assessing risk of bias. 13 Case-control studies were analysed using the Newcastle-Ottawa scale for assessing the quality of nonrandomised studies. 14 Case series were analysed using the National Institutes of Health study quality assessment tool. 
| Data extraction

| Assessment of heterogeneity
Methodological and clinical heterogeneity of data per study were evaluated. Variables were tested for statistical heterogeneity by applying the I 2 test to determine whether data could be pooled. An I 2 value less than 40% was taken to indicate minor heterogeneity; 40% to 75% moderate heterogeneity and greater than 75% substantial heterogeneity. 13 
| Meta-analysis
Meta-analysis for all outcomes was carried out using MedCalc statistical software version 15.4 (MedCalc Software, Ostend, Belgium).
Results were expressed as proportions with 95% confidence intervals (CI) as all outcomes were categorical variables. Pooled proportions were calculated using both the fixed and random effects model in case of homogeneity or heterogeneity respectively.
3 | RESULTS
| Study selection
The electronic literature search identified 70 367 studies published between 1990 and 2018 ( Figure 1) 86 reported a patient at 20 weeks' gestation experiencing a cardiorespiratory arrest prior to fetoscopy for laser photocoagulation.
The cause was considered to be a combination of morbid obesity, spinal anaesthesia, and aortocaval compression and not related to the procedure, which had not commenced. An immediate delivery was conducted by hysterotomy as part of maternal resuscitation, and the patient made a full recovery. Another study 47 reported brief maternal seizure-like activity during open fetal surgery, which was thought to be anaesthesia-related. Table 5 . Abbreviations: CI, confidence interval; GI, gastrointestinal; n, number of women. Pooled proportions calculated using random effect model for meta-analysis. e Upper GI bleed considered to be tocolysis-related (indomethacin). Abbreviations: DIC, disseminated intravascular coagulation; EXIT, ex utero intrapartum treatment; FETO, fetoscopic endoluminal tracheal occlusion; GI, gastrointestinal; MMC, myelomeningocele; n, number of women. Pooled proportions calculated using random effect model for meta-analysis. Upper GI bleed considered to be tocolysis-related (indomethacin).
| Overall maternal complication rates
3.9 | Maternal outcomes following the index pregnancy (long-term) In almost all studies of fetal surgery reviewed, long-term maternal follow up was not described. The seven studies that did so had a wide variation in the parameters described. Fertility does not appear to be negatively affected by fetal surgery, with the rates of de novo difficulties for conceiving in this review (3.81% following open fetal surgery and none following fetoscopic surgery) being comparable, if not less, than published rates of secondary infertility in the general population. 180 Similarly, the rates of miscarriage described (19.85% following Furthermore, we decided to pool data for meta-analysis despite having high heterogeneity in some results. Another weakness is the extraction of patient data from papers, which is prone to error given the variable reporting; it is possible that some patients had more than one complication and this was not noted or cumulative rates were as a consequence miscalculated.
This systematic review has identified a significant rate of maternal complications, which should be discussed with patients before embarking on fetal surgery. Large studies allow an estimation of the likelihood of these events, insomuch as the cases in these series are unselected and consecutive. Our systematic review search strategy may have missed relevant yet rare complications. For example, a letter to a journal editor describing maternal convulsions during general anaesthesia 188 was excluded as a case report according to our criteria.
In this circumstance, it appears that the patient was also part of the cohort of a study that was included, 47 but it is possible that other rare events published as case reports have been missed. An international, prospective registry of fetal and fetoscopic surgery, such as the Eurofoetus 189 and NAFTNet 190 registries, would be the best way to accurately determine complication types and rates and avoid missing rare complications.
| CONCLUSION
The maternal risks of fetal surgery are accepted by many patients and health care professionals for the possible benefit to the fetus. 191, 192 This systematic review finds that studies of fetal surgery focus on the fetal outcomes of the procedure, and many fail to describe maternal complications. Fetal surgery comes at a risk to the mother, which may be underestimated by fetal therapists because of under-reporting and variable reporting quality. In order to properly quantify maternal risks, outcomes should be reported consistently across all studies of fetal surgery, preferentially in prospective registries.
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